Antoine Mérien
Associate
Works at Bpifrance Life Sciences Venture
Investor profile | Builders Republic
About
Associate at Bpifrance Life Sciences Venture in Paris, Antoine Mérien invests in Series A and Series B with check sizes ranging from €3 to €10 million, focusing on health and biotechnology. His portfolio reflects a strong expertise in innovative therapies and medtech: he serves as a Board Observer at Eligo Bioscience (phage-based therapies), Enodia Therapeutics, Coave Therapeutics, HEPTA Medical, and May Health. His profile combines academic research and finance: he holds a Ph.D. from Université Paris-Saclay obtained after a Ph.D. at I-Stem (2017–2021), and he also has a Master’s degree from Sorbonne Université and an MSc from ESCP Business School.
Profile
- Role
- Associate
- Fund
- Bpifrance Life Sciences Venture
- Nationality
- French